Low risk of recurrence following artesunate–Sulphadoxine–pyrimethamine plus primaquine for uncomplicated Plasmodium falciparum and Plasmodium vivax infections in the Republic of the Sudan

BACKGROUND: First-line schizontocidal treatment for uncomplicated malaria in the Republic of the Sudan is artesunate (total dose 12 mg/kg) plus Sulphadoxine/pyrimethamine (25/1.25 mg/kg) (AS/SP). Patients with Plasmodium vivax are also treated with 14 days primaquine (total dose 3.5 mg/kg) (PQ). The...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamid, Muzamil Mahdi Abdel, Thriemer, Kamala, Elobied, Maha E., Mahgoub, Nouh S., Boshara, Salah A., Elsafi, Hassan M. H., Gumaa, Suhaib A., Hamid, Tassneem, Abdelbagi, Hanadi, Basheir, Hamid M., Marfurt, Jutta, Chen, Ingrid, Gosling, Roly, Price, Ric N., Ley, Benedikt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857106/
https://www.ncbi.nlm.nih.gov/pubmed/29548285
http://dx.doi.org/10.1186/s12936-018-2266-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857106/
https://www.ncbi.nlm.nih.gov/pubmed/29548285
http://dx.doi.org/10.1186/s12936-018-2266-9

Ejemplares similares